Compare Etsy Inc (ETSY) vs Travere Therapeutics Inc. Common Stock (TVTX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Etsy Inc vs Travere Therapeutics Inc. Common Stock — how do they compare? Etsy Inc trades at $83.2 (market cap $7.61B), while Travere Therapeutics Inc. Common Stock trades at $53.44 (market cap $5.02B). The key difference: Etsy Inc is the larger of the two by market cap, and Etsy Inc is trading nearer its 52-week high, Travere Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Etsy Inc for 67 Days and Travere Therapeutics Inc. Common Stock for 0 Days on average.
| ETSY | TVTX | |
|---|---|---|
Market Cap | $7.61B | $5.02B |
Volume | 3,831,386 | 2,060,842 |
Sector | Consumer Cyclical | Health |
52-Week High | $87.03 | $67.52 |
52-Week Low | $44.05 | $26.79 |
Typical Hold Time | 67 Days | 0 Days |
Enterprise Value | $9.56B | $5.15B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ETSY trades at $79.28, up 3.05% today, with a bullish technical signal and strong institutional interest. Recent earnings beats and a 71.4% gross margin highlight operational strength, though net income margin compressed to 5.65% in 2025. The stock is near its consensus price target of $85.94, with positive sentiment driven by AI initiatives and partnership renewals.
Outlook is cautiously optimistic given analyst support and growth initiatives, but risks include high debt-to-asset ratio (105.48% in 2025) and competitive e-commerce pressures. Upside hinges on AI-driven personalization boosting revenue, while margin pressure and macroeconomic headwinds pose challenges.
Travere Therapeutics (TVTX) trades at $51.80, down 0.42% on the day, with a neutral technical signal. The company reported strong revenue growth but persistent net losses, with a 2025 net income margin of -7.35%. Recent news includes new data presentations for its key drug FILSPARI and a CEO transition. Analyst consensus is strongly bullish with an 83.33% buy rating and a $70.60 price target, suggesting significant upside from the current price.
The outlook for TVTX hinges on the commercial success of FILSPARI, which shows promising sales growth, but profitability remains a challenge. Key risks include execution of the CEO transition, competitive pressures in nephrology treatments, and the company's ability to achieve sustained profitability. The high valuation multiples relative to negative earnings present a risk-reward balance for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Etsy Inc
Etsy operates a top-10 e-commerce marketplace operator in the U.S. and the U.K., with sizable operations in Germany, France, Australia, and Canada. The firm dominates an interesting niche, connecting buyers and sellers through its online market to exchange vintage and craft goods. With $13.5 billion in 2021 consolidated gross merchandise volume, the firm has cemented itself as one of the largest players in a quickly growing space, generating revenue from listing fees, commissions on sold items, advertising services, payment processing, and shipping labels. As of the end of 2021, the firm connected more than 96 million buyers and more than 7.5 million sellers on its marketplace properties: Etsy, Reverb (musical equipment), Elo7 (crafts in Brazil), and Depop (clothing resale).
Read more on ETSY →About Travere Therapeutics Inc. Common Stock
Travere Therapeutics Inc. is a biopharmaceutical company focused on rare kidney and metabolic diseases. Its lead product, FILSPARI (sparsentan), is an oral medication for adults with IgA nephropathy, and it also markets Thiola for cystinuria.
Read more on TVTX →
